These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2304356)
61. Characteristics of granulocyte-macrophage colony formation in chronic myelomonocytic leukemia: a comparative study with other myelodysplastic and myeloproliferative disorders. Yuo A; Miyazono K; Urabe A; Takaku F Jpn J Cancer Res; 1990 Aug; 81(8):820-6. PubMed ID: 2118895 [TBL] [Abstract][Full Text] [Related]
62. [Colony stimulating factor (CSF)--various aspects of its therapeutic use]. Zduńczyk A Pol Arch Med Wewn; 1990 Jul; 84(1):44-53. PubMed ID: 2251218 [No Abstract] [Full Text] [Related]
63. Inhibition of human bone marrow-derived stem cell colony formation (CFU-E, BFU-E, and CFU-GM) following in vitro exposure to organophosphates. Gallicchio VS; Casale GP; Watts T Exp Hematol; 1987 Dec; 15(11):1099-102. PubMed ID: 3678410 [TBL] [Abstract][Full Text] [Related]
64. Granulopoietic differentiation in long-term bone marrow cultures from children with congenital neutropenia. Coulombel L; Morardet N; Veber F; Leroy C; Mielot F; Fisher A; Teillet-Thiebaud F; Tchernia G; Griscelli C; Parmentier C Am J Hematol; 1988 Feb; 27(2):93-8. PubMed ID: 3341373 [TBL] [Abstract][Full Text] [Related]
65. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders. Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461 [TBL] [Abstract][Full Text] [Related]
66. Undetectable peripheral blood CFU-GM as a prognostic indicator in myelodysplastic syndrome. Tennant GB; Jacobs A Leuk Res; 1988; 12(11-12):961-2. PubMed ID: 3216676 [TBL] [Abstract][Full Text] [Related]
67. Abnormal megakaryopoiesis in patients with myelodysplastic syndromes: analysis of cellular and humoral defects. Geissler D; Zwierzina H; Pechlaner C; Gaggl S; Schmalzl F; Konwalinka G; Braunsteiner H Br J Haematol; 1989 Sep; 73(1):29-35. PubMed ID: 2679861 [TBL] [Abstract][Full Text] [Related]
68. A practical miniature long-term bone marrow culture system for investigating early myelodysplasia. Roberts IA; McMullin MF Leuk Res; 1992 Aug; 16(8):737-41. PubMed ID: 1528061 [TBL] [Abstract][Full Text] [Related]
69. Myelodysplastic syndrome (MDS)-associated inhibitory activity on haemopoietic progenitor cells. Ohmori M; Ohmori S; Ueda Y; Tohyama K; Yoshida Y; Uchino H Br J Haematol; 1990 Feb; 74(2):179-84. PubMed ID: 2180470 [TBL] [Abstract][Full Text] [Related]
70. In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes. Merchav S; Nielsen OJ; Rosenbaum H; Sharon R; Brenner B; Tatarsky I; Scigalla P; Wieczorek L Leukemia; 1990 Nov; 4(11):771-4. PubMed ID: 2232891 [TBL] [Abstract][Full Text] [Related]
71. CFU-gm colony formation of peripheral blood and bone marrow in adult acute leukemia at presentation, during remission, and at relapse. Jehn U; Wachholz K Int J Cell Cloning; 1985 Jul; 3(4):199-213. PubMed ID: 3860564 [TBL] [Abstract][Full Text] [Related]
72. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes. Visani G; Tosi P; Finelli C; Gamberi B; Zauli G; Cenacchi A; Fogli M; Colombini R; Tura S Haematologica; 1992; 77(2):142-5. PubMed ID: 1383105 [TBL] [Abstract][Full Text] [Related]
73. [Cytogenetic examination of bone marrow cells in stem cell diseases of myelodysplastic syndromes]. Werner M; Maschek HJ; Kaloutsi V; Buhr T; Kausche F; Delventhal S; Georgii A Verh Dtsch Ges Pathol; 1990; 74():139-43. PubMed ID: 1708572 [TBL] [Abstract][Full Text] [Related]
74. Modulation of responsiveness of chronic myelogenous leukemia granulocyte-macrophage colony-forming cells to growth regulation following in vivo treatment with recombinant gamma-interferon. Pelus LM; Vadhan-Raj S Am J Hematol; 1988 May; 28(1):21-6. PubMed ID: 3130750 [TBL] [Abstract][Full Text] [Related]
75. Beyond the Niche: Myelodysplastic Syndrome Topobiology in the Laboratory and in the Clinic. Flores-Figueroa E; Gratzinger D Int J Mol Sci; 2016 Apr; 17(4):553. PubMed ID: 27089321 [TBL] [Abstract][Full Text] [Related]
76. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation. Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448 [TBL] [Abstract][Full Text] [Related]
77. [Value of the in vitro culture of granulomonocytic germ cells (CFU-GM) in myelodysplastic syndromes]. Florensa L; Woessner S; Lafuente R; Almarcha J; Sans-Sabrafen J Sangre (Barc); 1985; 30(4-C):689-97. PubMed ID: 3867159 [No Abstract] [Full Text] [Related]
78. An assessment of myeloid colony-forming-cell generation in liquid human bone marrow cultures: influence of accessory cells and cytokines IL-1 alpha, beta and IL-6. Gooding RP; Riches PG; Gordon MY Int J Exp Pathol; 1993 Apr; 74(2):173-80. PubMed ID: 8499317 [TBL] [Abstract][Full Text] [Related]
79. The growth of myelodysplastic bone marrow in long-term cultures. Borbenyi Z; Cinkotai C; Harrison C; Testa NG Br J Cancer; 1987 Mar; 55(3):291-3. PubMed ID: 3567063 [No Abstract] [Full Text] [Related]